Sir Richard Sykes
Major Career Roles:
- Previously the Chair and Chief Executive of GlaxoSmithKline
- Chair of the UK Government Vaccine Taskforce
- Chair of The Royal Institution of Great Britain
- Chair of King Edward VII’s Hospital
- Chair for Omnicyte Ltd
- Non-Executive Director of PDS Biotechnology Corp.
- Chair of The UK Stem Cell Foundation
- International Advisory Board, of A*Star Biomedical Research Council, Singapore and Chancellor of Brunel University.
- Chair of NHS London
Other Career Highlights:
- President of the Research and Development Society
- Chair of NetScientific plc
- Chair of Imperial College Healthcare NHS Trust
- Chair of PDS Operating Corp
- Chair of British Pharma Group
- Chair of Frontier Smart Technology Group ltd
- Chair of Medeus Pharma Limited
- Vice Chair at Swiss life sciences company Lonza Group AG
- Deputy Chair Eurasian Natural Resources Corp
- Member of the President’s Committee of the Confederation of British Industry
Sir Richard Sykes has over 30 years of international senior leadership experience which gave him a multi-industry knowledge in pharmaceuticals, healthcare, mining, private equity. Richard gained this knowledge through working as Chair and CEO for FTSE 100, FTSE AIM, STOXX EUROPE 50 and private companies.
Sir Richard Sykes was previously the Chair and Chief Executive of GlaxoSmithKline. He currently serves as Chair of King Edward VII’s Hospital, Non-Executive Director of PDS Biotechnology and as joint Advisory Board Member for the Grantham Institute at Imperial College London and the Grantham Research Institute at LSE. Sir Richard is also the President of the Research and Development Society.
Sir Richard has held a number of senior appointments including , Chair of the UK Government Vaccine Taskforce, Chair of The UK Stem Cell Foundation, Chair and Chief Executive of Glaxo and Chair and Chief Executive Glaxo Wellcome plc following the acquisition of Wellcome. He led the company through the formation of GlaxoSmithKline plc, where he was Chair and CEO.
Sir Richard was also on the International Advisory Board, of A*Star Biomedical Research Council, Singapore and he was the Chancellor of Brunel University.
Other appointments include Chair of NetScientific plc, the Imperial College Healthcare NHS Trust, NHS London, PDS Operating Corp, British Pharma Group, The Royal Institution of Great Britain, Frontier Smart Technology Group ltd, Medeus Pharma Limited, Vice Chair at Swiss life sciences company Lonza Group AG, Senior Non-Executive Director of Eurasian Natural Resources Corp, a member of the President’s Committee of the Confederation of British Industry, a member of the UK Trade Policy Forum, Chair of the Task Force for Inward Investment in the UK Pharmaceutical Industry, a member of the Advisory Committee for Human Genome Research, a member of the Council for Industry & Higher Education and member of DTI’s Strategy Board. He was also a Senior Independent Director of Rio Tinto plc, Board Member of ContraFect Corp and a Non-Executive Chair of Circassia Holdings Ltd.
